Antibodies Could be
Used to Treat Alzheimer's Disease - IVIG Blood Antibody Treatment
Provides Lasting Benefits
July 18th 2006
New York researchers say that a mixture of purified human antibodies,
called intravenous immunoglobulin (IVIg), provides lasting benefits to
patients with Alzheimer's disease (AD). They say this is the first
study that shows that IVIg stabilizes or improves cognitive function in
Alzheimer patients when administered over a period of a year or more.
The compound bonds to beta amyloid (AB), which many researchers believe
is a central component causing plaque buildup in the brains of
Alzheimer’s patients. They believe that the IVIg compound helps clear
the AB from the brain and even helps block AB’s toxic effects.
The IVIg compound has been available for 30 years and the FDA has
approve IVIg for treating several immune disorders. It has been used by
hundreds of thousands of patients.